315 related articles for article (PubMed ID: 17763062)
1. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin.
Prokopowicz M; Przyjazny A
J Microencapsul; 2007 Nov; 24(7):682-701. PubMed ID: 17763062
[TBL] [Abstract][Full Text] [Related]
2. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.
Prokopowicz M
Acta Biomater; 2009 Jan; 5(1):193-207. PubMed ID: 18755642
[TBL] [Abstract][Full Text] [Related]
3. In-vitro controlled release of doxorubicin from silica xerogels.
Prokopowicz M
J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
[TBL] [Abstract][Full Text] [Related]
4. Uniform and size-tunable mesoporous silica with fibrous morphology for drug delivery.
Gai S; Yang P; Ma P; Wang L; Li C; Zhang M; Jun L
Dalton Trans; 2012 Apr; 41(15):4511-6. PubMed ID: 22373780
[TBL] [Abstract][Full Text] [Related]
5. Release profile of insulin entrapped on mesoporous materials by freeze-thaw method.
Tozuka Y; Sugiyama E; Takeuchi H
Int J Pharm; 2010 Feb; 386(1-2):172-7. PubMed ID: 19931606
[TBL] [Abstract][Full Text] [Related]
6. Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.
Contessotto L; Ghedini E; Pinna F; Signoretto M; Cerrato G; Crocellà V
Chemistry; 2009 Nov; 15(44):12043-9. PubMed ID: 19774561
[TBL] [Abstract][Full Text] [Related]
7. Polymer-mesoporous silica materials templated with an oppositely charged surfactant/polymer system for drug delivery.
Lin H; Zhu G; Xing J; Gao B; Qiu S
Langmuir; 2009 Sep; 25(17):10159-64. PubMed ID: 19552374
[TBL] [Abstract][Full Text] [Related]
8. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity.
Catauro M; Melisi D; Curcio A; Rimoli MG
J Biomed Mater Res A; 2008 Dec; 87(4):843-9. PubMed ID: 18200553
[TBL] [Abstract][Full Text] [Related]
9. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
Prokopowicz M
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300
[TBL] [Abstract][Full Text] [Related]
10. Tuning stability of mesoporous silica films under biologically relevant conditions through processing with supercritical CO2.
Li X; Barua S; Rege K; Vogt BD
Langmuir; 2008 Oct; 24(20):11935-41. PubMed ID: 18795807
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic property measurement of surfactant-templated mesoporous silica films using time-resolved single-molecule imaging.
Kennard R; DeSisto WJ; Giririjan TP; Mason MD
J Chem Phys; 2008 Apr; 128(13):134710. PubMed ID: 18397097
[TBL] [Abstract][Full Text] [Related]
12. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
Yang P; Quan Z; Lu L; Huang S; Lin J
Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
[TBL] [Abstract][Full Text] [Related]
13. The controlled release of drugs from emulsified, sol gel processed silica microspheres.
Radin S; Chen T; Ducheyne P
Biomaterials; 2009 Feb; 30(5):850-8. PubMed ID: 19010531
[TBL] [Abstract][Full Text] [Related]
14. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.
Morpurgo M; Teoli D; Pignatto M; Attrezzi M; Spadaro F; Realdon N
Acta Biomater; 2010 Jun; 6(6):2246-53. PubMed ID: 20035908
[TBL] [Abstract][Full Text] [Related]
15. YVO4:Eu3+ functionalized porous silica submicrospheres as delivery carriers of doxorubicin.
Cheng Z; Ma P; Hou Z; Wang W; Dai Y; Zhai X; Lin J
Dalton Trans; 2012 Feb; 41(5):1481-9. PubMed ID: 22124278
[TBL] [Abstract][Full Text] [Related]
16. One-pot preparation of silica-supported hybrid immobilized metal affinity adsorbent with macroporous surface based on surface imprinting coating technique combined with polysaccharide incorporated sol--gel process.
Li F; Li XM; Zhang SS
J Chromatogr A; 2006 Oct; 1129(2):223-30. PubMed ID: 16860332
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
Yang YJ; Tao X; Hou Q; Chen JF
Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels.
Kang GD; Cheon SH; Song SC
Int J Pharm; 2006 Aug; 319(1-2):29-36. PubMed ID: 16677786
[TBL] [Abstract][Full Text] [Related]
20. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
